[1]Angulo P.Obesity and nonalcoholic fatty liver disease[J].Nutr Rev, 2007, 65 (S1) :S57-63.
|
[2]Grant LM, Lisker MM.Nonalcoholic fatty liver disease[J].Ann Hepatol, 2004, 3 (3) :93-99.
|
[3] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南[J].中华肝脏杂志, 2006, 14 (2) :161-163.
|
[4]Bedogni G, Bellentani S.Fatty liver, howfrequent is it and why[J].Ann Hepatol, 2004, 3 (2) :63-65.
|
[5]Fan JG, Zhu J, Li XJ, et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.
|
[6]Gupte P, Amarapurkar D, Agal S, et al.Non-alcoholic steatohepa-titis in type2diabetes mellitus[J].Gastroenterol Hepatol, 2004, 19 (8) :854-858.
|
[7]Methta K, van Thiel DH, Shah N, et al.Nonalcoholic fatty liver dis-ease:pathogenesis and the role of antioxidants[J].Nutr Rev, 2002, 60 (9) :289-293.
|
[8]何淑梅, 孔俭, 牛俊奇.非酒精性脂肪性肝病研究现状及进展[J].中国老年学杂志, 2008, 28 (4) :725-727.
|
[9]展玉涛.非酒精性脂肪肝与心血管疾病[J].中华内科杂志, 2007, 46 (10) :868-869.
|
[10]Clark JM, Brancati FL, Diehl AM.The prevalence and etiology of elevated aminotransferase levels in the United States[J].Am J Gas-troenterol, 2003, 98 (5) :960-967.
|
[11]Schindhelm RK, Diamant M, Jacqueline M, et al.Alanine amin-otransferase as a marker of non-alcoholic fatty liver disease in rela-tion to type2diabetes mellitus and cardiovascular disease[J].Dia-betes Metab Res Rev, 2006, 22 (6) :437-443.
|
[12]Choudhury J, Sanyal AJ.Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease[J].Clin Liver Dis, 2004, 8 (3) :575-594.
|
[13]Newschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome[J].Am J Med Sci, 2005, 330 (6) :326-335.
|
[14]Bansilal S, Farkouh ME, Fuster V.Role of insulin resistance and hyperglycemia in the development of atherosclerosis[J].Am J Car-diol, 2007, 99 (4A) :6B-14B.
|
[15]Bradbury MW.Lipid metabolism and liver inflammation.Hepatic fatty acid uptake:possible role in steatosis[J].Am J Physiol Gas-trointest Liver Physiol, 2006, 290 (2) :G194-G198.
|
[1] | Sulian YANG, Rongjie SHI, Lihua LI. Value of Fetuin-A, Fetuin-B, and insulin resistance index in predicting nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(4): 694-699. doi: 10.12449/JCH240409 |
[2] | Heng ZHU, Weizong KONG, Guiqun HUANG, Yu BAI, Yingchun WANG. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2010-2015. doi: 10.3969/j.issn.1001-5256.2022.09.013 |
[3] | LI YongKang, YANG NenHong. Research advances in insulin resistance in chronic pancreatitis and pancreatic cancer[J]. Journal of Clinical Hepatology, 2020, 36(11): 2630-2632. doi: 10.3969/j.issn.1001-5256.2020.11.053 |
[4] | Dou AiHua, Hui Wei, Liu Mei, Wei LinLin, Zhao Juan, Ma ChunHua, Zheng XiaoQin, Xiong Fang, Yang Xue, Zhang Mei, Xu Bin. Association between rs2943650 mutation and insulin resistance in patients with chronic liver disease and type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2018, 34(11): 2379-2382. doi: 10.3969/j.issn.1001-5256.2018.11.022 |
[5] | Ding ZhiYong, Bu Le, Lu HongYan, Rao ZhengXuan. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2361-2365. doi: 10.3969/j.issn.1001-5256.2017.12.021 |
[6] | Liu DaJi, Chen QingFeng. Pathogenesis of insulin resistance and its impact on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2017.06.029 |
[7] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[8] | Huang YaoBin, Li HuanMin, Li ChunGuang. Association of cholecystectomy with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2014, 30(7): 644-646. doi: 10.3969/j.issn.1001-5256.2014.07.017 |
[9] | Xiang Yang, Ye JiaRun, Li XinPing. Safety and effectiveness of pioglitazone in the treatment of non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2007, 23(6): 434-435. |
[10] | Xu Hui, Wen QinSheng, Wang XuXia, Zhang YaFei, Li Jun, Gu BingQuan. The effect of cimetidine on the blood sugar, serum insulin and other indexes in NASH rats[J]. Journal of Clinical Hepatology, 2007, 23(2): 112-114. |
[11] | Xing LingXiang, He YongWen. Experiment study on nonalcoholic fatty liver model induced by injection of oxytetracycline intraperitoneally in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 29-31. |
[12] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[13] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[14] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[15] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[16] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[18] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[19] | Huang JiLiang, Wu Fang, Zhang XinRan, Wang DongHua, Zhao RuiZhi. Relationship between tumor necrosis factor-α and lnsulin resistance in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2002, 18(3): 166-167. |
[20] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |